Insider Selling: RadNet Inc. (NASDAQ:RDNT) Insider Sells 21,667 Shares of Stock

RadNet Inc. (NASDAQ:RDNT) insider Michael N. Murdock sold 21,667 shares of the stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $13.23, for a total value of $286,654.41. Following the sale, the insider now directly owns 100,575 shares of the company’s stock, valued at $1,330,607.25. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

NASDAQ RDNT traded down $0.17 during trading hours on Friday, reaching $13.18. 177,802 shares of the company’s stock were exchanged, compared to its average volume of 246,384. RadNet Inc. has a one year low of $9.97 and a one year high of $16.54. The company has a debt-to-equity ratio of 4.74, a quick ratio of 0.72 and a current ratio of 0.72. The stock has a market cap of $668.59 million, a price-to-earnings ratio of 19.97, a PEG ratio of 5.09 and a beta of 1.05.

RadNet (NASDAQ:RDNT) last issued its quarterly earnings results on Thursday, May 9th. The medical research company reported ($0.08) earnings per share for the quarter, hitting the consensus estimate of ($0.08). The company had revenue of $271.50 million during the quarter, compared to analysts’ expectations of $256.30 million. RadNet had a net margin of 3.53% and a return on equity of 22.38%. The business’s quarterly revenue was up 17.3% on a year-over-year basis. During the same period last year, the business earned ($0.15) EPS. On average, analysts predict that RadNet Inc. will post 0.35 EPS for the current year.

A number of analysts recently issued reports on RDNT shares. Zacks Investment Research raised RadNet from a “sell” rating to a “hold” rating in a research note on Tuesday, March 5th. BidaskClub cut RadNet from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 1st. Raymond James cut RadNet from a “strong-buy” rating to an “outperform” rating and increased their target price for the stock from $16.00 to $17.50 in a research note on Friday, March 15th. They noted that the move was a valuation call. ValuEngine cut RadNet from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Finally, TheStreet raised RadNet from a “c” rating to a “b-” rating in a research note on Friday, March 15th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $17.75.

Institutional investors and hedge funds have recently modified their holdings of the company. US Bancorp DE bought a new position in shares of RadNet during the 1st quarter worth approximately $31,000. Quantamental Technologies LLC bought a new position in shares of RadNet during the 1st quarter worth approximately $34,000. Financial Gravity Wealth Inc. bought a new position in shares of RadNet during the 1st quarter worth approximately $35,000. PNC Financial Services Group Inc. bought a new position in shares of RadNet during the 4th quarter worth approximately $36,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of RadNet by 157.8% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,624 shares of the medical research company’s stock worth $37,000 after acquiring an additional 2,218 shares in the last quarter. 64.10% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Insider Selling: RadNet Inc. (NASDAQ:RDNT) Insider Sells 21,667 Shares of Stock” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://transcriptdaily.com/2019/06/15/insider-selling-radnet-inc-nasdaqrdnt-insider-sells-21667-shares-of-stock.html.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

Featured Story: How the Consumer Price Index (CPI) is calculated?

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.